Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01

The development of new low cost inactivated polio virus based vaccines (IPV) is a high priority, and will be required to eradicate polio. In addition, such a vaccine constitutes the only realistic polio vaccine in the post-eradication era. One way to reduce the cost of a vaccine is to increase immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietrich, Jes, Andreasen, Lars Vibe, Andersen, Peter, Agger, Else Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067388/
https://www.ncbi.nlm.nih.gov/pubmed/24956110
http://dx.doi.org/10.1371/journal.pone.0100879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067388/
https://www.ncbi.nlm.nih.gov/pubmed/24956110
http://dx.doi.org/10.1371/journal.pone.0100879

Ejemplares similares